Brener, Zachary Z <br/><br/>
Bruton's tyrosine kinase inhibitors and the kidney: Focus on ibrutinib.  [electronic resource] 

 -  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners  Oct 2020 
 - 1735-1737 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1477-092X 
<br/><br/><label>Standard No.: </label>10.1177/1078155220904406  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--administration & dosage<br/>Aged<br/>Humans<br/>Kidney--drug effects<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Male<br/>Piperidines--administration & dosage<br/>Protein Kinase Inhibitors--adverse effects<br/>Tumor Lysis Syndrome--etiology<br/>Urate Oxidase--administration & dosage